Lista de obras - Vito Amoroso - Dominio Público Uruguay

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study

artículo científico publicado en 2018

A retrospective series of long-term survivors of metastatic breast cancer in complete remission

artículo científico publicado en 2005

Adjuvant bisphosphonates in patients with breast cancer: does the potency matter?

artículo científico publicado en 2015

An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial.

artículo científico publicado en 2005

Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy

scientific article published on 04 September 2019

BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine.

artículo científico publicado en 1998

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT study

artículo científico publicado en 2014

Biomarkers and histology of premalignant and malignant lesions.

artículo científico publicado en 1996

Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature.

artículo científico publicado en 2008

Circulating tumor cells as predictors of prognosis in metastatic breast cancer: clinical application outside a clinical trial

artículo científico publicado en 2011

Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials

artículo científico publicado en 2019

Current challenges in HER2-positive breast cancer.

artículo científico publicado en 2015

Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study

scientific article published on 23 July 2018

Excess of second tumors in denosumab-treated patients: a metabolic hypothesis

scientific article published on 25 June 2019

Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial

artículo científico publicado en 2005

IFN-α in advanced well-differentiated neuroendocrine tumors: the neglected drug?

artículo científico publicado en 2018

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).

artículo científico publicado en 2015

Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors.

artículo científico publicado en 2014

Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?

artículo científico publicado en 2008

Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery

artículo científico publicado en 2018

Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study

scientific article published on 16 January 2017

Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?

artículo científico publicado en 2015

Osteoblastic flare in a patient with advanced gastric cancer after treatment with pemetrexed and oxaliplatin: implications for response assessment with RECIST criteria.

artículo científico publicado en 2007

Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case

artículo científico publicado en 2018

Paraneoplastic nephrotic syndrome in advanced breast cancer patient. A case report.

artículo científico publicado en 2004

Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies

artículo científico publicado en 2014

Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study

artículo científico publicado en 2009

Regression of advanced neuroendocrine tumors among patients receiving placebo

artículo científico publicado en 2016

Serum Vitamin D and Prostate Cancer Prognosis: The Story Continues.

artículo científico publicado en 2016

Should adjuvant weekly paclitaxel be considered less efficacious than anthracyclines plus cyclophosphamide for lower-risk patients with early-stage breast cancer?

artículo científico publicado en 2014

Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis.

artículo científico publicado en 2018

Testosterone serum levels and prostate cancer prognosis: the double face of Janus

artículo científico publicado en 2014

The involvement of early stage breast cancer patients during oncology consultations in Italy: a multi-centred, randomized controlled trial of a question prompt sheet versus question listing.

artículo científico publicado en 2017

When Should Everolimus Be Administered in the Natural History of Pancreatic Neuroendocrine Tumors?

scientific article published on 23 January 2017

Lista de obras de Vito Amoroso

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study

A retrospective series of long-term survivors of metastatic breast cancer in complete remission

Adjuvant bisphosphonates in patients with breast cancer: does the potency matter?

An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial.

Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy

BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine.

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT study

Biomarkers and histology of premalignant and malignant lesions.

Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature.

Circulating tumor cells as predictors of prognosis in metastatic breast cancer: clinical application outside a clinical trial

Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials

Current challenges in HER2-positive breast cancer.

Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study

Excess of second tumors in denosumab-treated patients: a metabolic hypothesis

Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial

IFN-α in advanced well-differentiated neuroendocrine tumors: the neglected drug?

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).

Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors.

Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?

Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery

Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study

Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?

Osteoblastic flare in a patient with advanced gastric cancer after treatment with pemetrexed and oxaliplatin: implications for response assessment with RECIST criteria.

Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case

Paraneoplastic nephrotic syndrome in advanced breast cancer patient. A case report.

Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies

Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study

Regression of advanced neuroendocrine tumors among patients receiving placebo

Serum Vitamin D and Prostate Cancer Prognosis: The Story Continues.

Should adjuvant weekly paclitaxel be considered less efficacious than anthracyclines plus cyclophosphamide for lower-risk patients with early-stage breast cancer?

Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis.

Testosterone serum levels and prostate cancer prognosis: the double face of Janus

The involvement of early stage breast cancer patients during oncology consultations in Italy: a multi-centred, randomized controlled trial of a question prompt sheet versus question listing.

When Should Everolimus Be Administered in the Natural History of Pancreatic Neuroendocrine Tumors?